Clinical trial
A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American…
NCT00419952 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00419952 |
|---|---|
| Title | A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma. |
| Official title | A 52-week, Randomised, Double-blind, Parallel-group, Multi-centre, Phase IIIB Study Comparing the Long Term Safety of SYMBICORT® pMDI 160/4.5 mg x 2 Actuations Twice Daily to Budesonide HFA pMDI 160 mg x 2 Actuations Twice Daily in Adult/Adolescent (≥12 Years) African American Subjects With Asthma |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide/formoterol (SYMBICORT) pMDI, Budesonide HFA pMDI |
| Enrollment | 742 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 9, 2007 |
| Last update posted | Oct 30, 2012 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: